42 CFR 482.45 - Condition of participation: Organ, tissue, and eye procurement
| Cite as | 42 CFR 482.45 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
32 practice notes
-
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Proposed Changes to Medicaid Provider Enrollment; and Proposed Changes to the Medicare Shared Savings Program
...organ acquisition costs. --------------------------------------------------------------------------- \1472\ The hospital CoPs at 42 CFR 482.45(b)(1) require each TH to be a member of the OPTN and abide by its rules, which for THs include registering potential transplant recipients on the OP......
-
Organ procurement organizations; information disclosure,
...and tissue transplants with organs, eyes and tissues received from hospitals subject to section 1138(a) of the Act and the regulation at 42 CFR 482.45. The regulation requires every Medicare and Medicaid hospital to perform the following concerning organ, eye, and tissue procurement activit......
-
Human drugs, medical devices, and biological products:
Human cells, tissues, and cellular and tissue-based products; donors eligibility determination,
...the regulation issued by CMS requiring hospitals to notify organ procurement organizations (OPOs) upon patients' death or imminent death (42 CFR 482.45). The comment pointed out that OPOs might, in some instances, determine donor eligibility for tissue donors. The comment asserted that FDA ......
-
Part II
...the regulation issued by CMS requiring hospitals to notify organ procurement organizations (OPOs) upon patients' death or imminent death (42 CFR 482.45). The comment pointed out that OPOs might, in some instances, determine donor eligibility for tissue donors. The comment asserted that FDA ......
Request a trial to view additional results
1 firm's commentaries
-
Organ Transplant Rates Remain Low: What Hospitals Need to Know to About Their Obligation to Help
...target="_blank">party designated by the OPO of individuals whose death is imminent or who have died in the hospital." (42 CFR § 482.45). Hospitals retain the obligation to timely refer potential donors, even in the face of challenges related to, or derivative of, COVID-19, and in the absenc......
31 provisions
-
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Proposed Changes to Medicaid Provider Enrollment; and Proposed Changes to the Medicare Shared Savings Program
...organ acquisition costs. --------------------------------------------------------------------------- \1472\ The hospital CoPs at 42 CFR 482.45(b)(1) require each TH to be a member of the OPTN and abide by its rules, which for THs include registering potential transplant recipients on the OP......
-
Organ procurement organizations; information disclosure,
...and tissue transplants with organs, eyes and tissues received from hospitals subject to section 1138(a) of the Act and the regulation at 42 CFR 482.45. The regulation requires every Medicare and Medicaid hospital to perform the following concerning organ, eye, and tissue procurement activit......
-
Part II
...the regulation issued by CMS requiring hospitals to notify organ procurement organizations (OPOs) upon patients' death or imminent death (42 CFR 482.45). The comment pointed out that OPOs might, in some instances, determine donor eligibility for tissue donors. The comment asserted that FDA ......
-
Human drugs, medical devices, and biological products:
Human cells, tissues, and cellular and tissue-based products; donors eligibility determination,
...the regulation issued by CMS requiring hospitals to notify organ procurement organizations (OPOs) upon patients' death or imminent death (42 CFR 482.45). The comment pointed out that OPOs might, in some instances, determine donor eligibility for tissue donors. The comment asserted that FDA ......
Request a trial to view additional results